Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline Transcript

March 09, 2026 06:47:57 pm

Source: SeekingAlpha

2026-03-09 18:47:57 ET

Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline March 9, 2026 12:00 PM EDT...

For further details see:

Roth CH Acquisition I Co.

12.23% G/L:

$28.90 Last:

2,033,245 Volume:

$25.95 Open:

Market Cap $284,029,200

Float 7,447,250

Insiders Ownership 24.22%

Institutions 45

Short Percent 806141%

Industry Diversified Financial Services

Sector Finance

Country US

City Newport Beach